跳至主要内容
临床试验/JPRN-UMIN000008872
JPRN-UMIN000008872已完成未知

Phase II study of Paclitaxel and Nedaplatin for previously untreated patients with advanced squamous cell lung cancer. - Phase II study of Paclitaxel and Nedaplatin for previously untreated patients with advanced squamous cell lung cancer.

Tochigi Cancer Center0 个研究点目标入组 17 人开始时间: 2012年9月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Symptomatic Brain metastasis. 2.History of active double cancer. 3.Severe infection. 4.Severe comorbidity (heart failure Tendency to hemorrhages uncontrollable hypertension, uncontrollable diabetes, etc) 5.Interstitial pneumonia or pulmonary fibrosis detectable on X ray. 6.With a history of drug sensitivity. 7.Pregnant or lactating women or those who declined contraception. 8.Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.

研究者

相似试验